Evidence map›Paper›PMID 34989872›Full record

ArticleArchives of microbiology2022

Antimicrobial, antioxidant and antileishmanial activities of Ziziphus lotus leaves.

Khaoula Mkadmini Hammi, Rym Essid, Nadine Khadraoui, Riadh Ksouri, Hatem Majdoub, Olfa Tabbene

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Therapeutic efficacy ofFrontiers in nutrition · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Khaoula Mkadmini HammiLaboratoire des Plantes Aromatiques et Médicinales (LPAM), Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia.
Rym EssidLaboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia. essidrym@hotmail.com.ORCID http://orcid.org/0000-0002-5956-1318
Nadine KhadraouiLaboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia.
Riadh KsouriLaboratoire des Plantes Aromatiques et Médicinales (LPAM), Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia.
Hatem MajdoubLaboratoire des Interfaces et des Matériaux Avancés (LIMA), Faculté des Sciences de Monastir, Université de Monastir, Bd. de l'environnement, 5019, Monastir, Tunisia.
Olfa TabbeneLaboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia.
Center of Biotechnogy of Borj Cédria · TNUniversity of Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate antimicrobial and antioxidant activities of different fractions obtained from edible Tunisian Ziziphus Lotus leaves of Tozeur region. Different organic extracts were tested: cyclohexane, dichloromethane, ethyl acetate, n-butanol and water. Bio-guided fractionation revealed that dichloromethane fraction is the most active against S. aureus and Methicillin-resistant S. aureus strains. Moreover, this fraction showed the highest antileishmanial activity with IC

Indexed as

Anti-Infective AgentsMethicillin-Resistant Staphylococcus aureusZiziphusAnti-Bacterial AgentsAntioxidantsMicrobial Sensitivity TestsPlant ExtractsPlant LeavesStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsAntioxidantsPlant ExtractsAntileishmanial activityAntimicrobial activityAntioxidant activityFractionationPhenolic compoundsZiziphus Lotus leaves

Identifiers

PMID34989872
OpenAlexW4206642666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.